An Act To Increase the Availability of Nasal Naloxone in Community Settings
Maine Legislature, Session 130, LD 1428
Committee: Health and Human Services
Sponsors: DODGE, BRENNAN, HARNETT, MADIGAN, MORALES, STOVER, TEPLER, ZAGER, RAFFERTY
Amends: 22 MRSA §2353

Legislative Document
No. 1428
H.P. 1044
House of Representatives, April 12, 2021
An Act To Increase the Availability of Nasal Naloxone in 
Community Settings
Received by the Clerk of the House on April 8, 2021.  Referred to the Committee on Health 
and Human Services pursuant to Joint Rule 308.2 and ordered printed pursuant to Joint Rule 
401.
ROBERT B. HUNT
Clerk
Presented by Representative DODGE of Belfast.
Cosponsored by Representatives: BRENNAN of Portland, HARNETT of Gardiner, 
MADIGAN of Waterville, MORALES of South Portland, STOVER of Boothbay, TEPLER of 
Topsham, ZAGER of Portland, Senator: RAFFERTY of York.
Be it enacted by the People of the State of Maine as follows:
Sec. 1.  22 MRSA §2353, sub-§4-B is enacted to read:
4-B.  Community organizations; standing orders for nasal naloxone 
hydrochloride.  If a community organization opts to possess and administer nasal naloxone 
hydrochloride at the community organization's facility, acting under standing orders from 
a licensed health care professional authorized by law to prescribe nasal naloxone 
hydrochloride, the community organization shall operate in accordance with rules adopted 
by the department and the provisions of this subsection.
A.  Notwithstanding any provision of law to the contrary, a community organization 
may store at the organization's facility and dispense nasal naloxone hydrochloride and 
is not subject to the provisions of Title 32, chapter 117.
B.  A community organization shall obtain training in administration of nasal naloxone 
hydrochloride that meets the protocols and criteria established by the department.  A 
community organization may seek out an appropriate training entity to train the 
organization's employees in the administration of nasal naloxone hydrochloride and 
overdose identification and prevention.  Employees of the community organization 
who administer nasal naloxone hydrochloride and all other persons involved in the 
administration of the community organization shall successfully complete the training 
and possess documentation of having successfully completed the training from the 
training entity or community organization that conducted the training.
C.  A syringe services program certified by the Maine Center for Disease Control and 
Prevention or other entity that provides nasal naloxone hydrochloride shall provide 
unit-of-use packages of nasal naloxone hydrochloride to a community organization that 
has provided training described in paragraph B so that the community organization 
may possess and administer nasal naloxone hydrochloride to an individual who appears 
to be experiencing a drug-related overdose.
D. For purposes of this subsection, unless the context otherwise indicates, "community 
organization" means a private or nonprofit organization operating a facility that serves 
the community.
The department shall adopt rules to implement this subsection.  Rules adopted pursuant to 
this subsection are routine technical rules as defined in Title 5, chapter 375, subchapter 
2-A.
SUMMARY
This bill allows community organizations, which are defined as private or nonprofit 
organizations operating a facility that serves the community, to store and administer nasal 
naloxone hydrochloride upon a standing order from a licensed health care professional 
authorized by law to prescribe nasal naloxone hydrochloride.